Japanese Leisure Stock News

TSE:6702
TSE:6702IT

Is It Time To Reassess Fujitsu (TSE:6702) After Its Recent Share Price Pullback?

If you are wondering whether Fujitsu's current share price reflects its true worth, it helps to step back and look at both recent returns and what the underlying valuation signals are saying. The stock last closed at ¥3,112, with returns of 5.9% over 1 year, 75.0% over 3 years, and 100.0% over 5 years. The year-to-date move of 27.8% and recent 7-day and 30-day declines of 4.8% and 13.3% highlight that sentiment can shift quickly. Recent headlines around Fujitsu have focused on its position...
TSE:9508
TSE:9508Electric Utilities

Kyushu Electric Power Company (TSE:9508) Valuation Check As Board Weighs Holding Structure And Leadership Changes

Board meeting puts Kyushu Electric Power Company in focus Kyushu Electric Power Company (TSE:9508) has called a board meeting for March 26, 2026, to review a possible move to a holding company structure and potential changes to its Representative Director, drawing fresh attention to the stock. See our latest analysis for Kyushu Electric Power Company. The upcoming board meeting comes after a mixed stretch for the shares, with a 5.76% 7 day share price return but a 9.81% 30 day decline. The 1...
TSE:7181
TSE:7181Insurance

Is Japan Post Insurance’s Completed Share Buyback Shifting Its Capital Return Story (TSE:7181)?

Japan Post Insurance has now completed the share repurchase program announced on November 14, 2025, buying back 10,216,800 shares, or 2.77% of its outstanding stock, for ¥44,999.71 million by March 24, 2026. This completed buyback meaningfully reduces the share count and highlights the company’s recent focus on returning surplus capital to shareholders. We’ll now examine how the completed buyback program, and its impact on share count, may influence Japan Post Insurance’s investment...
TSE:285A
TSE:285ASemiconductor

Is It Too Late To Consider Kioxia Holdings (TSE:285A) After A 7x One Year Rally?

If you are wondering whether Kioxia Holdings is priced for perfection or still offers value, the recent share price is giving plenty to think about. The stock closed at ¥19,965 after a very large 1 year return of around 7x, even though the last 7 days and 30 days show 7.0% and 5.9% declines and the year to date gain sits at 75.9%. Recent coverage has circled around Kioxia's position in the semiconductor supply chain and its exposure to memory demand, with investors weighing how those themes...
TSE:6504
TSE:6504Electrical

Is Fuji Electric (TSE:6504) Pricing Look Compelling After Recent 22% Monthly Share Price Slide

If you are wondering whether Fuji Electric's current share price really reflects the underlying business, the next sections break down what the numbers are actually saying about value. The stock last closed at ¥10,810, with returns of 2.9% over 7 days, a 22.3% decline over 30 days, a 10.6% decline year to date, and gains of 73.3% over 1 year, 113.7% over 3 years, and 151.7% over 5 years. This gives plenty for valuation minded investors to think about. Recent coverage has focused on Fuji...
TSE:2593
TSE:2593Beverage

Assessing Ito En (TSE:2593) Valuation As Board Weighs New Subsidiary Via Company Split

Board meeting focus and why it matters for Ito En shareholders Ito En (TSE:2593) has called a board meeting for March 27, 2026 to review the establishment of a new subsidiary via a company split, a structural move that naturally puts the share price under the microscope for investors. See our latest analysis for Ito En. The upcoming company split decision comes after a mixed price pattern, with a 6.44% 7 day share price return contrasting with a 2.62% 30 day decline and a 53.29% 5 year total...
TSE:4519
TSE:4519Pharmaceuticals

Global's March 2026 Stocks Estimated Below Intrinsic Value

As global markets navigate the complexities of Middle East conflicts and energy price volatility, investor sentiment remains cautious amid mixed performances across major indices. In this environment, identifying undervalued stocks—those trading below their intrinsic value—can offer potential opportunities for investors seeking resilience against geopolitical and economic uncertainties.
TSE:4523
TSE:4523Pharmaceuticals

Does Strong Lecanemab Treatment Persistence Reshape The Bull Case For Eisai (TSE:4523)?

Eisai and its partners recently reported real-world data at the AD/PD 2026 conference showing that most early Alzheimer’s patients in the U.S. remained on intravenous lecanemab beyond 18 months, with persistence still above two-thirds at 24 months, broadly aligning with outcomes seen in the Phase 3 Clarity AD trial and its long-term extension. The new findings, alongside expanding approvals and filings for more convenient maintenance and subcutaneous lecanemab dosing, reinforce the therapy’s...
TSE:3923
TSE:3923Software

High Growth Tech Stocks in Asia for March 2026

The Asian markets have been navigating a complex landscape marked by energy price volatility and geopolitical tensions, with these factors significantly influencing investor sentiment and economic outlooks across the region. Amidst this backdrop, high growth tech stocks in Asia are drawing attention for their potential to offer robust returns despite broader market uncertainties. In such an environment, a good stock is often characterized by strong fundamentals, resilience to external shocks...
TSE:3086
TSE:3086Multiline Retail

How February’s 13.2% Sales Jump Will Impact J. Front Retailing (TSE:3086) Investors

In March 2026, J. Front Retailing Co., Ltd. reported that its consolidated sales for February rose 13.2%, with year‑to‑date sales up 3.2%. This acceleration in monthly and year‑to‑date sales offers a fresh data point on how the group’s renovation, inbound and content initiatives may be resonating with customers. With February’s strong 13.2% consolidated sales growth as a backdrop, we’ll now examine how this update influences J. Front Retailing’s investment narrative. Invest in the nuclear...
TSE:8795
TSE:8795Insurance

T&D Holdings (TSE:8795) Is Up 7.6% After Raising Revenue Outlook And Lifting Dividend Target

In March 2026, T&D Holdings, Inc. raised its fiscal 2026 ordinary revenue forecast to ¥3.42 trillion and lifted expected earnings per share to ¥237.45, citing stronger-than-anticipated insurance premium income from higher sales of single premium products, while leaving profit guidance unchanged. The company also increased its year-end dividend guidance to ¥68 per share and introduced a new policy targeting cash dividends of about 60% of five-year average Group adjusted profit, signaling a...
TSE:7004
TSE:7004Machinery

Kanadevia (TSE:7004) Valuation In Focus As Board Weighs Subsidiary Share Transfer

Board meeting puts Kanadevia’s group structure in focus Kanadevia (TSE:7004) has called a board meeting for March 26, 2026, to review and approve a potential share transfer involving a consolidated subsidiary, bringing attention to how any change might affect the wider group. See our latest analysis for Kanadevia. The upcoming board meeting lands after a mixed period for the stock, with a 7.92% year to date share price return and a 10.11% one year total shareholder return suggesting that...
TSE:2768
TSE:2768Trade Distributors

Sojitz Taps Predictive Health Testing To Broaden Asia Pacific Growth Story

Sojitz group company Royal Healthcare in Singapore has begun offering NEC Corporation's FonesVisuas Test, an advanced blood test that estimates the risk of multiple diseases. This marks Sojitz's entry into predictive health testing in Southeast Asia through its partnership with NEC and Royal Healthcare. The move expands Sojitz's presence in healthcare, adding a new dimension to its business portfolio in the Asia Pacific region. For investors tracking Sojitz (TSE:2768), this development adds...
TSE:9104
TSE:9104Shipping

Assessing Mitsui O.S.K. Lines (TSE:9104) Valuation After Elliott’s Undervaluation Call And Recent Share Price Momentum

Elliott Investment Management’s new statement on Mitsui O.S.K. Lines (TSE:9104) has pushed investor attention toward the company’s upcoming medium term management plan and the question of how the market values its shipping assets. See our latest analysis for Mitsui O.S.K. Lines. The Elliott statement lands after a strong run in the share price, with a 30 day share price return of 23.39% and a 90 day share price return of 51.93%. The 5 year total shareholder return of roughly 7x signals that...
TSE:7974
TSE:7974Entertainment

Is Nintendo (TSE:7974) Fairly Priced After Recent Share Price Swings?

Wondering whether Nintendo's share price reflects its true value today, or if the market is missing something that you could be early to? The stock recently closed at ¥9,215, with a 5.5% gain over the last 30 days, although returns sit at a 13.5% decline year to date and a 14.7% decline over the last year, set against an 87.7% gain over 3 years and 63.7% over 5 years. Recent coverage has focused on how Nintendo fits into the broader entertainment and gaming sector, including discussion of...
TSE:9602
TSE:9602Entertainment

How Toho’s Leadership Shakeup Across Film, Theater, and Real Estate Will Impact Toho (TSE:9602) Investors

On March 18, 2026, Toho Co., Ltd.’s board approved sweeping leadership changes, including Representative Director Yoshishige Shimatani stepping down to become Corporate Adviser and the planned retirement of several senior Executive Officers across its real estate, theatrical, and cinema businesses. These shifts reshuffle decision‑making power across Toho’s core operating groups, potentially signaling an internal rethink of how its film, theater, and property operations are led. With these...
TSE:4527
TSE:4527Personal Products

A Look At Rohto Pharmaceutical (TSE:4527) Valuation After Its New Share Buyback Plan

Rohto PharmaceuticalLtd (TSE:4527) has announced a share repurchase program, authorizing the buyback of up to 1,500,000 shares for ¥3,000 million. The initiative is intended to improve capital efficiency and support flexible capital policies. See our latest analysis for Rohto PharmaceuticalLtd. At a share price of ¥2,412.0, Rohto PharmaceuticalLtd has a 7 day share price return of 2.14% and a 1 year total shareholder return of 6.88%. The 3 year total shareholder return of 10.34% contrasts...
TSE:9505
TSE:9505Electric Utilities

Hokuriku Electric Power (TSE:9505) Valuation After Profit Guidance Cut And Mikuni Unit 1 Abolition

Hokuriku Electric Power (TSE:9505) cut its profit outlook for the year ending March 31, 2026, after deciding to abolish the Fukui Thermal Power Station Mikuni Unit 1 and recognize related impairment losses. See our latest analysis for Hokuriku Electric Power. The board’s decision on Mikuni Unit 1 and the resulting downgrade to profit guidance comes against a backdrop of a 13.31% 90 day share price return and a 94.79% 3 year total shareholder return. This suggests recent momentum has built on...
TSE:4528
TSE:4528Pharmaceuticals

Ono Pharmaceutical (TSE:4528) Files Ripretinib in Japan: Is Its Oncology Strategy Entering a New Phase?

Ono Pharmaceutical has submitted a manufacturing and marketing application in Japan for ripretinib, an oral tyrosine kinase inhibitor for advanced gastrointestinal stromal tumor that has progressed after prior chemotherapy, supported by positive global Phase 3 INVICTUS data showing significantly prolonged progression-free survival versus placebo. The filing is reinforced by ripretinib’s orphan drug status and its designation as a high medical-need therapy in Japan, highlighting its potential...
TSE:7936
TSE:7936Luxury

Is It Too Late To Consider ASICS (TSE:7936) After Its Strong Multi Year Rally?

Investors may be wondering if ASICS at ¥4,306 is still offering value after its strong run, or if most of the easy gains are now behind it. The share price shows a mix of short term pressure and longer term strength, with a 2.2% decline over 7 days and a 7.8% decline over 30 days, set against an 11.9% gain year to date and a 35.9% return over the last year. Over a multi year horizon the stock has delivered very large returns, with the 3 year performance and the 5 year performance each...
TSE:8316
TSE:8316Banks

Is Sumitomo Mitsui Financial Group (TSE:8316) Still Attractive After Its Strong Multi‑Year Rally?

Wondering if Sumitomo Mitsui Financial Group's current share price reflects its true worth, or if the market is mispricing this major Japanese bank. The stock closed at JP¥5,246 recently, with a 1.7% gain over the last 7 days, a 7.9% decline over 30 days, and returns of 1.2% year to date and 35.8% over the past year, while the 3 year and 5 year returns stand at 223.9% and 384.4% respectively. Recent coverage around large Japanese banks has focused on how investors are reassessing financial...
TSE:4568
TSE:4568Pharmaceuticals

Is There Now An Opportunity In Daiichi Sankyo (TSE:4568) After Multi‑Year Share Price Weakness

If you are wondering whether Daiichi Sankyo Company is attractively priced or simply reflecting its risks, the recent share performance provides a useful starting point before assessing valuation. The stock last closed at ¥2,930, with a 0.9% gain over the past week, a 2.2% decline over 30 days, and year-to-date and 1-year returns of 17.0% and 19.2% declines respectively, as well as a 37.0% decline over 3 years and a 0.7% decline over 5 years. Recent coverage around Daiichi Sankyo has focused...